Concepedia

Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome

Salam Zakko, Gary Barton, Eckhard Weber, Cornelia Dunger‐Baldauf, Aki Sebastian Ruhl

Alimentary Pharmacology & Therapeutics · 2011 · 30 citations · 24 references

DOIFull text

Open access

Abstract

DNK333 25 mg b.d. appears to be effective and well tolerated in women with IBS-D. Further studies with neurokinin antagonists are warranted.

References

24

The Interpretation of Interaction in Contingency Tables

Esther Simpson · Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1951 · 2.3K citations

, , +8

Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate.

Lauren J. O’Donnell, J. Virjee, K W Heaton · BMJ · 1990 · 544 citations · Full text

Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact

A. P. S. Hungin, Lin Chang, G. Richard Locke et al. · Alimentary Pharmacology & Therapeutics · 2005 · 486 citations · Full text

Abnormal Intestinal Permeability in Subgroups of Diarrhea-Predominant Irritable Bowel Syndromes

Simon P. Dunlop, John M. Hebden, Eugene Campbell et al. · The American Journal of Gastroenterology · 2006 · 475 citations

Rome II: The functional gastrointestinal disorders

Howard Mertz · Gastroenterology · 2001 · 384 citations

, , +3